Incanthera ltd
WebResearch Services Headquarters MANCHESTER Locations 76 KING STREET MANCHESTER, GB Get directions Employees at INCANTHERA LIMITED Suzanne Brocks Head of Communications, Company Secretary,... WebBetween 2014 and 2024 Pawel served as IP and R&D Manager and later as a Chief Operating Officer in UK based oncology focused business Incanthera Ltd. During this time, he has been responsible for portfolio of over 100 patents and 4 new therapeutics drugs in preclinical and early clinical stage of development.
Incanthera ltd
Did you know?
WebApr 2, 2024 · Incanthera plc, an oncology therapeutics company, focuses on the drug discovery and development of targeted medicines for the treatment of cancer. The company’s near to market asset include Sol, a topical product for the treatment of solar keratosis and the prevention of skin cancers. WebIncanthera PLC is a UK-based, dermatology and oncology therapeutics company focusing on drug discovery and development of targeted medicines for the treatment of cancer. Deep …
WebMore for INCANTHERA PLC (11026926) Registered office address 76 King Street, Manchester, England, M2 4NH . Company status Active Company type Public limited Company Incorporated on 23 October 2024. Accounts. Next accounts made up to 31 March 2024 due by 30 September 2024 ... WebIncanthera plc is a United Kingdom-based company, which is focused on treatment options with technologies in oncology and dermatology. Its lead product and focus is Sol, a topical product developed for the treatment of solar keratosis and the prevention of skin cancers. ... All services are provided by Stockopedia Ltd, United Kingdom (company ...
WebThe pipeline guide evaluates Bladder Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. Web'Incanthera Ltd Company Profile' is a complete analysis of the company's operations, strategies, outlook and historic performance. The research work analyzes key strategies …
WebFeb 2, 2014 · Incanthera has raised a total of £650K in funding over 1 round. This was a Venture - Series Unknown round raised on Feb 2, 2014. Incanthera is funded by The North …
WebFeb 28, 2024 · Developer Incanthera Class Antineoplastics; Colchicum alkaloids; Drug conjugates; Peptides Mechanism of Action Vascular disrupting agents Orphan Drug Status No New Molecular Entity Yes Highest Development Phases No development reported Breast cancer; Colorectal cancer; Lung cancer; Prostate cancer Most Recent Events cundalls meet the teamWebThe ICT has already successfully used this technology to improve the therapeutic index of a colchicine derivative (ICT2588, see Cancer Research, 2010, 70, 6902-6912), which is now licensed to University of Bradford spin-out company Incanthera Ltd (www.incanthera.com) and received global press coverage at the British Science Festival 2011 (e.g ... easy arctic monkeys riffs electric guitarWebN4 Pharma top competitors include: Ailse Oncology Ltd, Vaccicure Ltd, Incanthera Ltd, InnoCore How do I contact N4 Pharma? N4 Pharma contact info: Phone number: +44 1332690061 Website: www.n4pharma.com What does N4 Pharma do? easy architecture schools to get intoWebApr 13, 2024 · Incanthera PLC is a specialist oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It identifies and develops innovative solutions... cundalls yorkshire limitedWebIncanthera is a specialist oncology company focused on innovative technologies in oncology and dermatology. It seeks to identify and develop innovative solutions to current clinical, … easy architecture paintingWebSafe Harbor: The aforementioned statements and any future correspondence made by InCapta, Inc. (the Company) may be forward looking in nature, particularly related to the … easy argy trapWebIn pursuit of best-in-class small molecule drugs to treat cancer and immunologic diseases cundall yorkshire